BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6143 related articles for article (PubMed ID: 19175111)

  • 1. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetry for I125 and Pd103 eye plaque brachytherapy.
    Thomson RM; Taylor REP; Rogers DWO
    Med Phys; 2008 Dec; 35(12):5530-5543. PubMed ID: 28525130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sci-Sat AM(2): Brachy-03: Monte Carlo dosimetry for I-125 and Pd-103 eye plaque brachytherapy.
    Thomson RM; Taylor R; Rogers D
    Med Phys; 2008 Jul; 35(7Part3):3416. PubMed ID: 28512876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
    Melhus CS; Rivard MJ
    Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy.
    Thomson RM; Furutani KM; Pulido JS; Stafford SL; Rogers DW
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1261-9. PubMed ID: 20472360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
    Astrahan MA; Szechter A; Finger PT
    Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
    Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
    Lesperance M; Inglis-Whalen M; Thomson RM
    Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
    Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
    J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dose calculation methods for brachytherapy of intraocular tumors.
    Rivard MJ; Chiu-Tsao ST; Finger PT; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Rogers DW; Thomson RM; Nath R
    Med Phys; 2011 Jan; 38(1):306-16. PubMed ID: 21361199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 308.